Why the study?
The study sought to investigate the association between cardiometabolic multimorbidity patterns and dementia-related neuropsychiatric symptoms among multiregional and ethnic seniors.
Does cardiometabolic multimorbidity increase the risk of dementia-related neuropsychiatric symptoms in older adults?
Does cardiometabolic multimorbidity increase the risk of dementia-related neuropsychiatric symptoms in older adults?
Metabolic multimorbidity (hypertension, hyperlipidemia, diabetes) is significantly associated with a higher presence and short-term incidence of affective neuropsychiatric syndromes in older adults, whereas cardio-cerebrovascular multimorbidity is not.
May warrant closer monitoring for affective symptoms in older adults with metabolic multimorbidity; extends cardiometabolic-dementia links but remains hypothesis-generating.
Introduction To investigate the association between cardiometabolic multimorbidity (CMM) patterns and dementia‐related neuropsychiatric symptoms (NPSs) among multiregional and ethnic seniors. Methods Four Asian studies (discovery) and UK Biobank (validation) were included. CMM was defined as two or more of hypertension, hyperlipidemia, diabetes mellitus, stroke, and heart disease. The latent class analysis identified CMM patterns. Two‐step individual participant data (IPD) and Cox regressions explored associations between CMM and the presence and short‐term (1–2 years) incidence of four neuropsychiatric subsyndromes: psychosis, hyperactivity, affective, and apathy. Results A total of 2950 Asian and 40,424 UK participants were included. Metabolic multimorbidity (≥2 of hypertension, hyperlipidemia, and diabetes mellitus) was associated with the presence (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 1.00–1.81; and 1.93, 1.73–2.16; in the respective data set), and incidence (hazard ratio [HR] = 3.91, 1.53–10.01; and 6.94, 2.52–19.07) of affective subsyndrome. Cardio‐cerebrovascular multimorbidity (≥2 of hypertension, stroke, and heart disease) was not associated with any NPSs. Discussion Metabolic multimorbidity may exacerbate the neuropsychiatric disturbances of possible dementia. Highlights Four Asian multiregional and ethnic studies were included as the discovery data set, with the UK Biobank being applied as the validation data set. Metabolic multimorbidity had a higher presence and short‐term incidence of affective syndromes. Cardio‐cerebrovascular multimorbidity was not associated with any neuropsychiatric symptoms.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: